Correlation Between Sana Biotechnology and Prime Medicine,

Can any of the company-specific risk be diversified away by investing in both Sana Biotechnology and Prime Medicine, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sana Biotechnology and Prime Medicine, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sana Biotechnology and Prime Medicine, Common, you can compare the effects of market volatilities on Sana Biotechnology and Prime Medicine, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sana Biotechnology with a short position of Prime Medicine,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sana Biotechnology and Prime Medicine,.

Diversification Opportunities for Sana Biotechnology and Prime Medicine,

0.43

Correlation Coefficient

Sana Biotechnology  Prime Medicine,

Very weak diversification

The 3 months correlation between Sana and Prime is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Sana Biotechnology and Prime Medicine, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prime Medicine, Common and Sana Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sana Biotechnology are associated (or correlated) with Prime Medicine,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prime Medicine, Common has no effect on the direction of Sana Biotechnology i.e., Sana Biotechnology and Prime Medicine, go up and down completely randomly.

Pair Corralation between Sana Biotechnology and Prime Medicine,

Given the investment horizon of 90 days Sana Biotechnology is expected to under-perform the Prime Medicine,. But the stock apears to be less risky and, when comparing its historical volatility, Sana Biotechnology is 1.15 times less risky than Prime Medicine,. The stock trades about -0.15 of its potential returns per unit of risk. The Prime Medicine, Common is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  341.00  in Prime Medicine, Common on August 26, 2024 and sell it today you would lose (21.00) from holding Prime Medicine, Common or give up 6.16% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Sana Biotechnology  vs.  Prime Medicine, Common

Sana Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sana Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Prime Medicine, Common

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Prime Medicine, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Etf's primary indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the fund shareholders.

Pair Trading with Sana Biotechnology and Prime Medicine,

The main advantage of trading using opposite Sana Biotechnology and Prime Medicine, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sana Biotechnology position performs unexpectedly, Prime Medicine, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prime Medicine, will offset losses from the drop in Prime Medicine,'s long position.

The idea behind Sana Biotechnology and Prime Medicine, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.